Wasatch Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-572,907
| Closed | -$7.96M | – | 261 |
|
|
2023
Q3 | $7.96M | Sell |
572,907
-626,443
| -52% | -$8.71M | 0.05% | 155 |
|
|
2023
Q2 | $27.6M | Buy |
1,199,350
+161,936
| +16% | +$3.72M | 0.17% | 107 |
|
|
2023
Q1 | $30.7M | Buy |
1,037,414
+205,193
| +25% | +$6.08M | 0.19% | 99 |
|
|
2022
Q4 | $20.8M | Sell |
832,221
-228,340
| -22% | -$5.7M | 0.14% | 131 |
|
|
2022
Q3 | $23.1M | Buy |
1,060,561
+489,917
| +86% | +$10.7M | 0.16% | 122 |
|
|
2022
Q2 | $11.2M | Buy |
570,644
+333,287
| +140% | +$6.56M | 0.07% | 166 |
|
|
2022
Q1 | $10M | Sell |
237,357
-3,594
| -1% | -$152K | 0.05% | 185 |
|
|
2021
Q4 | $15.3M | Sell |
240,951
-415
| -0.2% | -$26.3K | 0.06% | 177 |
|
|
2021
Q3 | $14.2M | Buy |
241,366
+2,264
| +0.9% | +$133K | 0.06% | 191 |
|
|
2021
Q2 | $11.6M | Buy |
+239,102
| New | +$11.6M | 0.05% | 201 |
|